16Dec 2017

THE PREVALENCE OF AVASCULAR NECROSIS IN ADULTS WITH SICKLE CELL DISEASE IN KING FAHAD HOSPITAL.

  • Medical Intern, Taibah university.
  • Consultant Hematologist.
  • OB/GYN Resident, MMCH.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Introduction: Sickle cell disease is the commonest genetic blood disorder. Every year, around 330,000 babies are born with inherited hemoglobin disorder, 83% of them have Sickle cell disease. Avascular necrosis is a serious complication threatening the quality of patients? lives. Objective: To study the prevalence of avascular necrosis in adult patients with sickle cell disease at King Fahad Hospital. Methods: A retrospective study carried on (220) sickle cell disease patients mainly from Madinah region in Saudi Arabia from 2010 to 2017.The data were collected from medical records and use of questionnaire format . Results: According to the results of this study most patients were males, aged between 26 and 40 years. Of 220 sickle cell anemia patients attended at King Fahad Hospital in a period of 7 years, (7.3%) had avascular necrosis. The majority of patients have a lower hemoglobin and hematocrit levels (7.0 - 10.4 g / dl and less than 40%, respectively). About 57.9% of patients take hydroxyurea. 86.1% have normal serum calcium levels . Conclusion: This study aimed to assess the prevalence of avascular necrosis in adult patients with sickle cell anemia at King Fahad Hospital. Of 220 sickle cell anemia patients attended at King Fahad Hospital in a period of 7 years, 16 (7.3%) had avascular necrosis. Also, we demonstrate relation between avascular necrosis and some risk factors like low hemoglobin and hematocrit levels, frequent blood transfusion, use of hydroxyurea and long-term use of high dose steroid.

  1. Bezerra G, Silva Junior D, De E, Daher F, Airton F, Da Rocha C. Osteoarticular involvement in sickle cell disease. Rev Bras HematolHemoter. 2012;34(2):156-164. doi:10.5581/1516-8484.20120036.
  2. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86(6):480-487. doi:10.2471/BLT.06.036673.
  3. Saraf SL, Molokie RE, Nouraie M, et al. Differences in the clinical and genotypic presentation of sickle cell disease around the world. PaediatrRespir Rev. 2017;15(1):4-12. doi:10.1016/j.prrv.2013.11.003.
  4. El-Hazmi MA, Al-Hazmi AM, Warsy AS. Sickle cell disease in Middle East Arab countries. Indian J Med Res. 2011;134(November):597-610. doi:10.4103/0971-5916.90984.
  5. Jastaniah W. Epidemiology of sickle cell disease in Saudi Arabia. Ann Saudi Med. 2011;31(3):289-293. doi:10.4103/0256-4947.81540.
  6. Chung SM, Ralston EL. Necrosis of the femoral head associated with sickle-cell anemia and its genetic variants. A review of the literature and study of thirteen cases. J Bone Joint Surg Am. 1969;51(1):33-58.
  7. Osunkwo I. An update on the recent literature on sickle cell bone disease. CurrOpinEndocrinol Diabetes Obes. 2013;20(6):539-546. doi:10.1097/01.med.0000436192.25846.0b.
  8. Ballas SK, Kesen MR, Goldberg MF, et al. Beyond the Definitions of the Phenotypic Complications of Sickle Cell Disease: An Update on Management. Sci World J. 2012;2012:1-55. doi:10.1100/2012/949535.
  9. Adekile AD, Gupta R, Yacoub F, Sinan T, Al-Bloushi M, Haider MZ. Avascular necrosis of the hip in children with sickle cell disease and high Hb F: magnetic resonance imaging findings and influence of alpha-thalassemia trait. ActaHaematol. 2001;105(1):27-31. doi:46529.
  10. Mont MA, Zywiel MG, Marker DR, McGrath MS, Delanois RE. The natural history of untreated asymptomatic osteonecrosis of the femoral head: a systematic literature review. J Bone Joint Surg Am. 2010;92(12):2165-2170. doi:10.2106/JBJS.I.00575.
  11. Almeida A, Roberts I. Bone involvement in sickle cell disease. Br J Haematol. 2005;129(4):482-490. doi:10.1111/j.1365-2141.2005.05476.x.
  12. Hernigou P, Bachir D, Galacteros F. The natural history of symptomatic osteonecrosis in adults with sickle-cell disease. J Bone Joint Surg Am. 2003;85-A(3):500-504.
  13. Mahadeo K.M., Oyeku S., Taragin B. et A. Increased prevalence of osteonecrosis of the femoral head in children and adolescents with sickle-cell disease. Am J Hematol. 2011;86(9):806-808.
  14. Milner PF, Kraus AP, Sebes JI, et al. Osteonecrosis of the humeral head in sickle cell disease. ClinOrthopRelat Res. 1993;(289):136-143.
  15. Milner PF, Kraus AP, Sebes JI, et al. Sickle cell disease as a cause of osteonecrosis of the femoral head. N Engl J Med. 1991;325(21):1476-1481. doi:10.1056/NEJM199111213252104.
  16. Akinyoola AL, Adediran IA, Asaleye CM. Avascular necrosis of the femoral head in sickle cell disease in Nigeria: a retrospective study. Niger Postgrad Med J. 2007;14(3):217-220.
  17. Marouf R, Gupta R, Haider MZ, Al-Wazzan H, Adekile AD. Avascular necrosis of the femoral head in adult Kuwaiti sickle cell disease patients. ActaHaematol. 2003;110(1):11-15. doi:10.1159/000072406.
  18. Osunkwo I, Ziegler TR, Alvarez J, et al. High dose vitamin D therapy for chronic pain in children and adolescents with sickle cell disease: Results of a randomized double blind pilot study. Br J Haematol. 2012;159(2):211-215. doi:10.1111/bjh.12019.
  19. Nolan VG, Nottage KA, Cole EW, Hankins JS, Gurney JG. Prevalence of Vitamin D deficiency in sickle cell disease: A systematic review. PLoS One. 2015;10(3):1-12. doi:10.1371/journal.pone.0119908.
  20. Al-qurashi MM, El-mouzan MI, Al-herbish AS, Al-salloum AA, Al-omar AA. adolescents. 2008;966(C):1480-1483.
  21. Powars DR, Hiti A, Ramicone E, Johnson C, Chan L. Outcome in Hemoglobin SC Disease : A Four-Decade Observational Study of Clinical , Hematologic , and Genetic Factors. 2002;215(May 2001):206-215. doi:10.1002/ajh.10140.
  22. Ware HE, Brooks AP, Toye R, Berney SI. SICKLE SILENT DISEASE NECROSIS AND OF THE of. 1991;73(6):947-949.
  23. Hawker H, Unit TE. Haematological factors associated with avascular necrosis of the femoral head in homozygous sickle cell disease. 1982:29-34.
  24. Ugwu AO, Ibegbulam OG, Nwagha TU, Madu AJ, Ocheni S, Okpala I. Clinical and Laboratory Predictors of Frequency of Painful Crises among Sickle Cell Anaemia Patients in Nigeria. 2017;11(6):10-13. doi:10.7860/JCDR/2017/26446.10042.
  25. Journal B, Gabriel P, Ana S, et al. RevistaBrasileira de Hematologia e Hemoterapia Original article Clinical and laboratory profile of patients with sickle cell anemia. Rev Bras HematolHemoter. 2016;39(1):40-45. doi:10.1016/j.bjhh.2016.09.007.
  26. Mohammed S, Addael S, Suleiman S, Adzakul F, Richards J. Serum calcium , parathyroid hormone , and vitamin D status in children and young adults with sickle cell disease. 1993:45-51.
  27. Adewoye AH, Chen TC, Ma Q, et al. Sickle cell bone disease : Response to vitamin D and calcium. 2008;(October 2007):271-274. doi:10.1002/ajh.21085.
  28. Avascular necrosis of the femoral head in sickle cell disease in pediatric patients suffering from hip dysfunction. 2016.
  29. Chan KL, Mok CC. Glucocorticoid-Induced Management Avascular Bone Necrosis : Diagnosis and. 2012:449-457.
  30. Wang GJ, Cui Q, Balian G. The Nicolas Andry award. The pathogenesis and prevention of steroid-induced osteonecrosis. ClinOrthopRelat Res. 2000;(370):295-310.
  31. Naidoo P, Bs MB, Liu VJ, Bs MB, Sci BM, Mautone M. Lower limb complications of diabetes mellitus : a comprehensive review with clinicopathological insights from a dedicated high-risk diabetic foot multidisciplinary team. 2015;(February). doi:10.1259/bjr.20150135.
  32. Molcho S, Peer A, Berg T, Futerman B, Khamaisi M. Diabetes Microvascular Disease and the Risk for bisphosphonate-related Osteonecrosis of the Jaw: A Single Center Study. 2017;98(December):1807-1812. doi:10.1210/jc.2013-2434.

[Sarah A. Elmaghraby, Saud H. Balelah, Hibah A. Almahdi, Hatem M. Habib, Duha D. Al-loqmani, Reem J. Tharwat, Nada H. Mahmoud, Fatma S. Baik and Fatema K. Al-Madani. (2017); THE PREVALENCE OF AVASCULAR NECROSIS IN ADULTS WITH SICKLE CELL DISEASE IN KING FAHAD HOSPITAL. Int. J. of Adv. Res. 5 (Dec). 860-868] (ISSN 2320-5407). www.journalijar.com

Sarah Ahmed Elmaghraby
King Fahad Hospital

DOI:

Article DOI: 10.21474/IJAR01/6031      
DOI URL: http://dx.doi.org/10.21474/IJAR01/6031

Download Full Paper

Download PDF No. of Downloads: 23 | No. of Views: 167